Worldquant Millennium Advisors LLC United Therapeutics Corp Transaction History

Worldquant Millennium Advisors LLC

$10.9 Billion
Q2 2024

A detailed history of Worldquant Millennium Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 42,250 shares of UTHR stock, worth $15.1 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

42,250

Previous 59,426 28.9%

Holding current value

$15.1 Million

Previous $13.7 Million 1.41%

% of portfolio

0.12%

Previous 0.17%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $3.92 Million - $5.48 Million	-17,176 Reduced 28.9%	42,250 $13.5 Million
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $589,074 - $697,380	-2,795 Reduced 4.49%	59,426 $13.7 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $2.93 Million - $3.5 Million	-13,624 Reduced 17.96%	62,221 $13.7 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $5.33 Million - $6.25 Million	25,186 Added 49.72%	75,845 $17.1 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $2.78 Million - $3.16 Million	13,555 Added 36.53%	50,659 $11.2 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $7.9 Million - $10.2 Million	37,104 New	37,104 $8.31 Million
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $326,905 - $519,241	-4,298 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$107.15 - $126.84 $21,430 - $25,368	200 Added 4.88%	4,298 $504,000
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $80,613 - $102,340	795 Added 24.07%	4,098 $446,000
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $27,200 - $30,940	239 Added 7.8%	3,303 $422,000
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $309,892 - $362,501	3,064 New	3,064 $347,000

Others Institutions Holding UTHR

# of Institutions

619

Shares Held

45M

Call Options Held

368K

Put Options Held

410K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.

Account

Worldquant Millennium Advisors LLC United Therapeutics Corp Transaction History